A detailed history of Bell Asset Management LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bell Asset Management LTD holds 38,672 shares of CRL stock, worth $7.81 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares
38,672
Previous 43,439 10.97%
Holding current value
$7.81 Million
Previous $10.3 Million 2.05%
% of portfolio
1.55%
Previous 1.57%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$203.52 - $273.43 $970,179 - $1.3 Million
-4,767 Reduced 10.97%
38,672 $10.5 Million
Q4 2023

Feb 13, 2024

SELL
$164.52 - $238.84 $1.13 Million - $1.64 Million
-6,868 Reduced 13.65%
43,439 $10.3 Million
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $856,119 - $958,136
4,403 Added 9.59%
50,307 $9.86 Million
Q2 2023

Aug 11, 2023

BUY
$183.71 - $210.25 $789,218 - $903,234
4,296 Added 10.32%
45,904 $9.65 Million
Q1 2023

May 12, 2023

SELL
$191.89 - $259.92 $47,588 - $64,460
-248 Reduced 0.59%
41,608 $8.4 Million
Q4 2022

Feb 13, 2023

SELL
$197.11 - $250.07 $77,070 - $97,777
-391 Reduced 0.93%
41,856 $9.12 Million
Q3 2022

Nov 10, 2022

BUY
$182.44 - $250.54 $475,256 - $652,656
2,605 Added 6.57%
42,247 $8.31 Million
Q2 2022

Aug 12, 2022

BUY
$204.13 - $302.4 $1.7 Million - $2.52 Million
8,349 Added 26.68%
39,642 $8.48 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $1.76 Million - $2.49 Million
6,885 Added 28.21%
31,293 $8.89 Million
Q4 2021

Feb 11, 2022

BUY
$351.38 - $448.68 $2.81 Million - $3.58 Million
7,983 Added 48.6%
24,408 $9.2 Million
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $323,451 - $397,804
-868 Reduced 5.02%
16,425 $6.78 Million
Q2 2021

Aug 13, 2021

SELL
$294.17 - $371.65 $26,769 - $33,820
-91 Reduced 0.52%
17,293 $6.4 Million
Q1 2021

May 14, 2021

SELL
$249.67 - $299.48 $1.01 Million - $1.21 Million
-4,047 Reduced 18.88%
17,384 $5.04 Million
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $245,088 - $278,892
1,104 Added 5.43%
21,431 $5.36 Million
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $752,976 - $971,244
-4,289 Reduced 17.42%
20,327 $4.6 Million
Q2 2020

Aug 13, 2020

SELL
$118.84 - $189.72 $2.04 Million - $3.26 Million
-17,197 Reduced 41.13%
24,616 $4.29 Million
Q1 2020

May 14, 2020

BUY
$98.9 - $178.34 $865,276 - $1.56 Million
8,749 Added 26.46%
41,813 $5.28 Million
Q4 2019

Feb 13, 2020

BUY
$126.05 - $152.76 $4.17 Million - $5.05 Million
33,064 New
33,064 $5.05 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.3B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Bell Asset Management LTD Portfolio

Follow Bell Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bell Asset Management LTD with notifications on news.